NLRP3 and Insulin resistance: Statins impair insulin signaling causing statin-induced insulin resistance in adipose tissue, coincident with activation of NLR family pyrin domain-containing 3 (NLRP3) inflammasome and impaired insulin-stimulated lipogenesis in adipocytes [7,8].